Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound Zhixue Powder is a traditional Chinese medicine (TCM) formulation used primarily for its hemostatic (bleeding-stopping) properties. It is typically composed of multiple herbal ingredients that act synergistically to stop bleeding and promote tissue repair. The exact composition can vary by manufacturer or region but often includes herbs such as Cirsium japonicum (Japanese thistle), Sanguisorba officinalis (great burnet), and Bletilla striata, among others. The mechanism of action is believed to involve promoting vasoconstriction, enhancing platelet aggregation, and supporting wound healing through various phytochemicals present in the constituent herbs. It is mainly indicated for internal or external bleeding conditions in TCM practice.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Compound Zhixue Powder.